Vancomycin and Fecal Microbiota Transplant in a Single Patient With Autism Spectrum Disorder
NCT04878718 · Status: NO_LONGER_AVAILABLE · Type: EXPANDED_ACCESS
Last updated 2025-06-08
Summary
Single patient with ASD will be treated with Vancomycin followed by FMT.
Conditions
Interventions
- BIOLOGICAL
-
Fecal Microbiota Transplant; Vancomycin
Subject will be treated with vancomycin followed by fecal microbiota transplant
Sponsors & Collaborators
-
ProgenaBiome
lead OTHER
Principal Investigators
-
Sabine Hazan, MD · ProgenaBiome
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum Disorders and Gastrointestinal Symptoms
NCT07105267 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Treatment of Initial Clostridium Difficile Infection
NCT03107169 ·Status: COMPLETED ·Phase: NA
-
Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders
NCT03408886 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Explore Efficacy of FMT Treating Childhood ASD Patients
NCT04142255 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection
NCT02237859 ·Status: UNKNOWN ·Phase: PHASE4
-
Fecal Microbiota Transplantation for Severe Clostridium Difficile Infection
NCT03427229 ·Status: COMPLETED ·Phase: PHASE2
-
Fecal Microbiota Therapy for Recurrent Clostridium Difficile Infection
NCT02686645 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Autologous Fecal Therapy
NCT02046525 ·Status: COMPLETED ·Phase: PHASE2
-
FMT for Multidrug Resistant Organism Reversal
NCT02312986 ·Status: COMPLETED ·Phase: PHASE1
-
Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics
NCT07261826 ·Status: RECRUITING
-
Primary Prophylaxis of Clostridioides Difficile Infection With Oral Vancomycin
NCT07221708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder
NCT03819439 ·Status: COMPLETED
-
Oral Vancomyin for Primary Clostridium Difficile Infection Prophylaxis in Patients Receiving High-Risk Antibiotics
NCT02951702 ·Status: COMPLETED ·Phase: PHASE4
-
Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea
NCT02801656 ·Status: WITHDRAWN ·Phase: PHASE3
-
Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections
NCT02774382 ·Status: UNKNOWN ·Phase: PHASE3
-
Vancomycin for the Treatment of NAAT(+)/Toxin(-) C. Difficile
NCT03827447 ·Status: COMPLETED ·Phase: PHASE1
-
Fecal Microbiota Transplantation for Relapsing Clostridium Difficile Infection
NCT02743234 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study of Fecal Microbiota Transplantation in the Treatment of Antibiotic-associated Diarrhea
NCT05990972 ·Status: COMPLETED ·Phase: NA
-
Oral Vancomycin to Prevent Recurrent C Difficile Infection With Antibiotics
NCT03466502 ·Status: COMPLETED ·Phase: PHASE4
-
FMT for MDRO Colonization in Solid Organ Transplant
NCT02816437 ·Status: WITHDRAWN ·Phase: PHASE1
-
Fecal Microbiota Transplantation for CRE/VRE
NCT03479710 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)
NCT03829878 ·Status: WITHDRAWN ·Phase: PHASE2
-
Mucosal Versus Fecal Microbiota in FMT
NCT02133651 ·Status: COMPLETED
-
Fecal Microbiota Transplant for Primary CDI
NCT03795233 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Fecal Microbiota Transplantation as a Strategy to Eradicate Resistant Organisms
NCT02543866 ·Status: RECRUITING ·Phase: PHASE1